Penel N - Search Results

1

Cousin S, Le Loarer F, Crombé A, Karanian M, Minard-Colin V, Penel N. Cousin S, et al. Among authors: penel n. Bull Cancer. 2019 Jan;106(1):73-83. doi: 10.1016/j.bulcan.2018.11.004. Epub 2018 Dec 4. Bull Cancer. 2019. PMID: 30527817 Review. French.

2

[Frequency of genetic diseases and cancer antecedents in 493 adults with visceral or soft tissue sarcomas].

Penel N, Depadt G, Vilain MO, Vanseymortier L, Ceugnart L, Taieb S, Mirabel X, Deligny N, Chevalier A, Baranzelli MC, Pichon F, Hoguet D, Robin YM, Lartigau E. Penel N, et al. Bull Cancer. 2003 Oct;90(10):887-95. Bull Cancer. 2003. PMID: 14706917 Free article. French.

3

[Interest of imaging for the monitoring of a treated cancer: simplified use of likelyhood ratio. The example of soft tissue tumor].

Taieb S, Penel N, Ceugnart L. Taieb S, et al. Among authors: penel n. Bull Cancer. 2006 Dec;93(12):1201-6. Bull Cancer. 2006. PMID: 17182376 Free article. French.

4

[Methodological approaches of clinical studies with targeted therapies].

Penel N, Saleron J, Lansiaux A, Clisant S, Adenis A, Fournier C, Duhamel A, Bonneterre J. Penel N, et al. Bull Cancer. 2008 Feb;95(2):185-90. doi: 10.1684/bdc.2008.0575. Bull Cancer. 2008. PMID: 18304903 Free article. Review. French.

5

A paradigm shift in tumour response evaluation of targeted therapy: the assessment of novel drugs in exploratory clinical trials.

Cousin S, Taieb S, Penel N. Cousin S, et al. Among authors: penel n. Curr Opin Oncol. 2012 May;24(3):338-44. doi: 10.1097/CCO.0b013e3283528b73. Curr Opin Oncol. 2012. PMID: 22418613 Review.

6

Management of "unfavourable" carcinoma of unknown primary site: synthesis of recent literature.

Amela EY, Lauridant-Philippin G, Cousin S, Ryckewaert T, Adenis A, Penel N. Amela EY, et al. Among authors: penel n. Crit Rev Oncol Hematol. 2012 Nov;84(2):213-23. doi: 10.1016/j.critrevonc.2012.03.003. Epub 2012 Apr 11. Crit Rev Oncol Hematol. 2012. PMID: 22503530 Review.

7

Do anti-angiogenic therapies prevent brain metastases in advanced renal cell carcinoma?

Vanhuyse M, Penel N, Caty A, Fumagalli I, Alt M, Zini L, Adenis A. Vanhuyse M, et al. Among authors: penel n. Bull Cancer. 2012 Dec;99(12):100-6. doi: 10.1684/bdc.2012.1672. Bull Cancer. 2012. PMID: 23220100 Free article.

8

Sorafenib in patients with progressive epithelioid hemangioendothelioma: a phase 2 study by the French Sarcoma Group (GSF/GETO).

Chevreau C, Le Cesne A, Ray-Coquard I, Italiano A, Cioffi A, Isambert N, Robin YM, Fournier C, Clisant S, Chaigneau L, Bay JO, Bompas E, Gauthier E, Blay JY, Penel N. Chevreau C, et al. Among authors: penel n. Cancer. 2013 Jul 15;119(14):2639-44. doi: 10.1002/cncr.28109. Epub 2013 Apr 15. Cancer. 2013. PMID: 23589078 Free article. Clinical Trial.

9

Activity endpoints reported in soft tissue sarcoma phase II trials: quality of reported endpoints and correlation with overall survival.

Penel N, Cousin S, Duhamel A, Kramar A. Penel N, et al. Crit Rev Oncol Hematol. 2013 Nov;88(2):309-17. doi: 10.1016/j.critrevonc.2013.05.004. Epub 2013 May 22. Crit Rev Oncol Hematol. 2013. PMID: 23706377 Review.

10

[Docetaxel and prostate cancer: Early but not too early].

Penel N, Ryckewaert T, Amela EY. Penel N, et al. Bull Cancer. 2015 Sep;102(9):710-2. doi: 10.1016/j.bulcan.2015.06.006. Epub 2015 Jul 30. Bull Cancer. 2015. PMID: 26235414 French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

439 results

Search Page